Congress trades
Fresenius Medical Care AG & Co. KGaA (FMS)
Free on iOS and Android.
About Fresenius Medical Care AG & Co. KGaA
from the company's filings and listing, as of Oct 20, 2026- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Chief executive
- Helen Giza
- Employees
- 108,165
- Listed since
- Sep 17, 1996
- Market value
- $11.7B
- Price to earnings (12 mo)
- 11.8
- Net income per share (12 mo)
- $1.87in US dollars, from price and P/E
- Dividend yield
- 3.82%
Earnings
6 reported quarters · next on Nov 3, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 3, 2026 | $0.66 | $0.62 | $5.6B | $5.5B | EPS beatRevenue beat |
| Q1 FY2026reported May 5, 2026 | $0.53 | $0.59 | $5.4B | $5.4B | EPS missRevenue in line |
| Q4 FY2025reported Feb 24, 2026 | $0.83 | $0.65 | $6.0B | $5.7B | EPS beatRevenue beat |
| Q3 FY2025reported Nov 4, 2025 | $0.64 | $0.59 | $5.7B | $4.8B | EPS beatRevenue beat |
| Q2 FY2025reported Aug 5, 2025 | $0.52 | $0.50 | $5.6B | $5.0B | EPS beatRevenue beat |
| Q1 FY2025reported May 6, 2025 | $0.44 | $0.43 | $5.4B | $5.1B | EPS beatRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Shares vs prior qtr | % of shares out |
|---|---|---|---|---|
| Pzena Investment Management LLC | $339.0M | 14,992,081 | -0.4% | 2.78% |
| Morgan Stanley | $98.3M | 4,347,748 | +75.0% | 0.81% |
| Dodge & Cox | $86.5M | 3,826,910 | 0.0% | 0.71% |
| Fiduciary Management Inc | $66.4M | 2,937,829 | -34.2% | 0.54% |
| Brandes Investment Partners, LP | $43.3M | 1,916,090 | +18.9% | 0.36% |
| Millennium Management LLC | $35.5M | 1,571,805 | -4.2% | 0.29% |
| Todd Asset Management LLC | $29.5M | 1,305,386 | +0.7% | 0.24% |
| Goldman Sachs Group Inc | $20.3M | 898,668 | +9.9% | 0.17% |
| BlackRock, Inc. | $19.5M | 860,302 | +37.1% | 0.16% |
| Teachers Retirement System of the State of Kentucky | $18.5M | 816,200 | 0.0% | 0.15% |
| Quantinno Capital Management LP | $11.9M | 527,966 | +54.7% | 0.10% |
| O'Shaughnessy Asset Management, LLC | $10.5M | 465,587 | +126.1% | 0.09% |
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in FMS
8 disclosures of 8 on record · median 38d of the 45 allowedSince the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 24, 2026), not the member's result. Not investment advice.
| Member | Type | Action | Amount disclosed | Stock since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Daniel S. Goldman | Stock | Sale | $1,001 - $15,000 | -4.7%After the saleS&P 500 +72.9% · -77.7 pts vs S&P 500 | Jul 10, 2023 | Aug 13, 2023 | 34d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | +34.9%After the saleS&P 500 +93.8% · -58.9 pts vs S&P 500 | Sep 2, 2022 | Oct 13, 2022 | 41d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -26.0%After the saleS&P 500 +64.0% · -89.9 pts vs S&P 500 | Dec 14, 2021 | Jan 27, 2022 | 44d |
| Michael T. McCaul | Stock | Purchase | $15,001 - $50,000 | -45.4%S&P 500 +82.5% · -127.9 pts vs S&P 500 | Jun 18, 2021 | Jul 16, 2021 | 28d |
| Michael T. McCaul | Stock | Purchase | $15,001 - $50,000 | -38.2%S&P 500 +94.5% · -132.7 pts vs S&P 500 | Mar 19, 2021 | Apr 19, 2021 | 31d |
| Michael T. McCaul | Stock | Purchase | $15,001 - $50,000 | -35.2%S&P 500 +99.2% · -134.3 pts vs S&P 500 | Feb 2, 2021 | Mar 30, 2021 | 56d |
| Michael T. McCaul | Stock | Purchase | $50,001 - $100,000 | -45.7%S&P 500 +100.8% · -146.5 pts vs S&P 500 | Jan 14, 2021 | Feb 25, 2021 | 42d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | -27.5%After the saleS&P 500 +215.9% · -243.4 pts vs S&P 500 | Dec 21, 2018 | Jan 4, 2019 | 14d |
Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no since-the-trade figure is computed from them.
Every Congress trade in FMS, filterable by party, chamber, type and account.
Questions
Which members of Congress have traded FMS?
Daniel S. Goldman, Michael T. McCaul and Josh Gottheimer disclosed FMS transactions in the filings shown here.
How quickly are FMS trades disclosed?
Congressional disclosures took a median of 38 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 26, 2026.